Related Experiment Videos

Immunoreactive human epidermal growth factor concentrations in amniotic fluid, umbilical artery and vein serum, and

S M Scott1, G G Buenaflor, D N Orth

  • 1Harbor-UCLA medical Center, Torrance, Calif.

Biology of the Neonate
|January 1, 1989
PubMed

Insights

Immunoreactive human epidermal growth factor (IR-hEGF) was found in the placenta, amniotic fluid, and cord blood during pregnancy. Its increasing concentration suggests a role for EGF in perinatal development.

Area of Science:

  • Perinatal Biology
  • Developmental Biology
  • Reproductive Medicine

Background:

  • Human Epidermal Growth Factor (hEGF) plays critical roles in cell growth and differentiation.
  • Understanding the presence and role of hEGF during fetal development is crucial for perinatal health.

Purpose of the Study:

  • To measure immunoreactive hEGF (IR-hEGF) levels in various perinatal samples.
  • To investigate the distribution and concentration changes of IR-hEGF throughout gestation.

Main Methods:

  • Samples collected from 27 full-term and 14 preterm infants.
  • Analysis of IR-hEGF in amniotic fluid, amniotic membranes, placenta (fetal and maternal sides), and umbilical cord blood (artery and vein).

Main Results:

  • IR-hEGF was detected in the human placenta, amniotic fluid, and cord blood during the latter half of gestation.
  • Concentrations of IR-hEGF in placental tissue, amniotic fluid, and cord blood increased with advancing gestational age.

Conclusions:

  • The presence and progressive increase of IR-hEGF suggest a significant role for EGF during perinatal development.
  • hEGF may be a key factor influencing fetal growth and maturation in the perinatal period.

Related Concept Videos